Sun Life/$SLF
1D1W1MYTD1Y5YMAX
Capital at risk
About Sun Life
Sun Life Financial is one of the Big Three Canadian life insurers. The Canadian business contributed around 35% of its 2025 adjusted earnings. In that segment, the firm provides health, life insurance, and annuity products to individual and group customers. Its US business is mostly group health and contributed about 17% of the firm's adjusted earnings in 2025. Sun Life also offers life insurance and wealth products in several Asian markets with a strong presence in Hong Kong and the Philippines. The Asia segment contributed around 18% of adjusted 2024 earnings. Its asset management business had around CAD 1.2 trillion total assets under management or administration at the end of 2025 and represents around 30% of the firm's earnings.
- Ticker
- $SLF
- Sector
- Finance
- Primary listing
- NYSE
- Employees
- 32,151
- Headquarters
- Toronto, Canada
- Website
- www.sunlife.com
Sun Life Metrics
BasicAdvanced
$45B
18.92
$4.28
0.83
$2.66
3.43%
Price and volume
Market cap
$45B
Beta
0.83
52-week high
$84.38
52-week low
$57.22
Average daily volume
990K
Dividend rate
$2.66
Financial strength
Current ratio
53.577
Quick ratio
50.161
Long term debt to equity
57.922
Total debt to equity
58.012
Dividend payout ratio (TTM)
63.11%
Interest coverage (TTM)
9.01%
Profitability
EBITDA (TTM)
3,979.284
Gross margin (TTM)
40.88%
Net profit margin (TTM)
9.52%
Operating margin (TTM)
14.15%
Effective tax rate (TTM)
22.08%
Revenue per employee (TTM)
$804,260
Management effectiveness
Return on assets (TTM)
0.78%
Return on equity (TTM)
13.09%
Valuation
Price to earnings (TTM)
18.918
Price to revenue (TTM)
1.749
Price to book
2.55
Price to tangible book (TTM)
6.58
Price to free cash flow (TTM)
13.683
Free cash flow yield (TTM)
7.31%
Free cash flow per share (TTM)
5.918
Dividend yield (TTM)
3.28%
Forward dividend yield
3.43%
Growth
Revenue change (TTM)
4.08%
Earnings per share change (TTM)
4.87%
3-year revenue growth (CAGR)
6.16%
10-year revenue growth (CAGR)
2.20%
3-year earnings per share growth (CAGR)
8.16%
10-year earnings per share growth (CAGR)
5.96%
3-year dividend per share growth (CAGR)
8.51%
10-year dividend per share growth (CAGR)
8.93%
What the Analysts think about Sun Life
Analyst ratings (Buy, Hold, Sell) for Sun Life stock.
Analyst projections of the future price of Sun Life stock.
Bulls say / Bears say
Sun Life’s second-quarter adjusted EPS of C$2.02 topped IBES consensus forecasts of C$1.95 by C$0.07, underscoring robust core profitability. (Reuters)
The Canadian segment drove strong performance in Q2, with underlying net income rising 23% year-over-year to C$427 million on higher fee income and insurance margin expansion. (Reuters)
Asia underlying net income climbed 18% year-over-year to C$222 million in Q2, reflecting continued market share gains and product diversification in key hubs like Hong Kong and the Philippines. (Reuters)
Evercore ISI downgraded Sun Life Financial to “In Line” from “Outperform”, citing limited upside to forward earnings per share versus consensus and valuation pressures. (Investing.com)
The firm highlighted persistent net outflows at MFS, Sun Life’s asset management arm, pointing to headwinds in fee-based revenue generation. (Investing.com)
Evercore also flagged the U.S. stop-loss and dental businesses requiring further operational refinement, along with regulatory uncertainty in Asia’s MCV segment, underscoring execution risks. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Sept 2026.
Sun Life Financial Performance
Revenues and expenses
Sun Life Earnings Performance
Company profitability
Upcoming events
Sun Life News
AllArticlesVideos
Funds containing Sun Life
AllEURGBPUSD
Fund name | Fund size | $SLF weighting |
|---|---|---|
iShares MSCI Canada€SXR2 | €2.1B | 1.51% |
iShares MSCI Canada£CSCA | £1.8B | 1.51% |
iShares Ageing Population€AGED | €822M | 0.53% |
VanEck Morningstar Developed Markets Dividend Leaders€TDIV | €754M | 0.51% |
VanEck Morningstar Developed Markets Dividend Leaders£TDGB | £655M | 0.51% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.